Results 31 to 40 of about 9,011 (201)

Role of calcium desensitization in the treatment of myocardial dysfunction after deep hypothermic circulatory arrest [PDF]

, 2013
Introduction Rewarming from deep hypothermic circulatory arrest (DHCA) produces calcium desensitization by troponin I (cTnI) phosphorylation which results in myocardial dysfunction.
Faggian, Giuseppe, Giacomazzi, Alice, Hallström, Seth, Linardi, Daniele, Luciani, Giovanni, Mazzucco, Alessandro, Milani, Elisabetta, Rungatscher, Alessio, Scarabelli, Tiziano M, Tessari, Maddalena   +9 more
core   +3 more sources

Le lévosimendan en cardiologie et chirurgie cardiaque sous circulation extracorporelle

Avicenna Medical Research, 2023
Introduction : le lévosimendan est un agent inodilatateur utilisé avec succès dans le traitement de l’insuffisance cardiaque aigue et chronique.
Sayad, M Abdelbaki, Mehyaoui
doaj   +1 more source

Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials. [PDF]

, 2019
Current pharmacological therapies for heart failure with reduced ejection fraction are largely either repurposed anti-hypertensives that blunt overactivation of the neurohormonal system or diuretics that decrease congestion.
Ahmad, T, Allen, LA, Böhm, M, Desai, NR, Lindenfeld, J, McCullough, M, Miller, PE, Psotka, M, Riello, R, Rosano, GMC, Teerlink, JR   +10 more
core   +2 more sources

Levosimendan in decompensated heart failure patients: efficacy in a Brazilian cohort. Results of the BELIEF study [PDF]

, 2008
FUNDAMENTO: A levosimendana é um novo agente inodilatador que aumenta a contratilidade cardíaca pela sensibilização ao Ca(2+) e induz vasodilatação por meio da ativação dos canais KATP/BKCa.
ALBUQUERQUE, Denilson, BAIMA, Jader, BARRETTO, Antonio Carlos Pereira, BOCCHI, Edimar Alcides, Grupo de Estudos de Insuficiência Cardíaca da Sociedade Brasileira de Cardiologia - Estudo BELIEF, LAGE, Silvia, MOREIRA, Maria da Consolação, RASSI, Salvador, RIBEIRO, Jorge Pinto, VILAS-BOAS, Fábio   +9 more
core   +4 more sources

Inhaled levosimendan versus intravenous levosimendan in patients with pulmonary hypertension undergoing mitral valve replacement

Annals of Cardiac Anaesthesia, 2018
Context: Inhaled levosimendan may act as selective pulmonary vasodilator and avoid systemic side effects of intravenous levosimendan, which include decrease in systemic vascular resistance (SVR) and systemic hypotension, but with same beneficial effect ...
Tanveer Singh Kundra, P S Nagaraja, K S Bharathi, Parminder Kaur, N Manjunatha   +4 more
doaj   +1 more source

Use of levosimendan in hemodynamic management of heart failure in two neonates with intracranial arteriovenous shunts: a case series

Italian Journal of Pediatrics, 2023
Background The hemodynamic status of newborns with intracranial arteriovenous shunts (AVSs) may be extremely complex. Mini-invasive hemodynamic monitoring through innovative techniques such as Near-Infrared Spectroscopy (NIRS) and Pressure Recording ...
Francesca Landolfo, Paola Giliberti, Domenico Umberto De Rose, Flaminia Pugnaloni, Alessandra Santisi, Claudia Columbo, Ludovica Martini, Maria Paola Ronchetti, Luca Di Chiara, Alessandra Toscano, Carlo Gandolfo, Andrea Dotta, Irma Capolupo   +12 more
doaj   +1 more source

Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure [PDF]

, 2018
BackgroundAdult critically ill patients often suffer from acute circulatory failure and those with low cardiac output may be treated with inotropic agents.
Adamopoulos, Alhashemi, Alvarez, Alvarez, Arrigo, Bergh, Brouwers, Cholley, Coletta, De Backer, De Backer, Duygu, Feneck, Follath, Gamper, Garcia-Gonzalez, Gordon, Guyatt, Guyatt, Guyatt, Guyatt, Hajjej, Hultcrantz, Iyisoy, Jammer, Jentzer, Karlsberg, Koster, Laine, Landoni, Landoni, Levin, Levin, Mahmoud, Mebazaa, Mehta, Memis, Moller, Morelli, Perner, Perner, Qaseem, Rochwerg, Samimi-Fard, Savovic, Vaitsis, Vincent, Wetterslev, Wilkman, Yilmaz, Yontar   +50 more
core   +3 more sources

Cardiorenal syndrome [PDF]

, 2015
published_or_final_versio
Pai, MCP
core   +1 more source

Levosimendan for sepsis-induced myocardial dysfunction: friend or foe?

Frontiers in Cardiovascular Medicine
Sepsis-induced myocardial dysfunction (SIMD) involves reversible myocardial dysfunction. The use of inotropes can restore adequate cardiac output and tissue perfusion, but conventional inotropes, such as dobutamine and adrenaline, have limited efficacy ...
Xinxin Du, Xinxin Du, Fang Xiong, Yafei Hou, Xiangyou Yu, Pengfei Pan   +5 more
doaj   +1 more source

Levosimendán preoperatorio en cirugía coronaria con disfunción ventricular severa: ¿tiene sentido?

Cirugía Cardiovascular, 2021
Resumen: Introducción y objetivos: Numerosos estudios han demostrado los beneficios del levosimendán en pacientes con insuficiencia cardiaca crónica y aguda; sin embargo, los resultados son contradictorios cuando se analiza el uso de levosimendán previo
Elena Roselló-Díez, Eduardo Astrosa, Sandra Casellas, Manel Tauron, Josefina Galán, Antonino Ginel, José Montiel   +6 more
doaj   +1 more source